✨ Medicines Approval Notices




23 SEPTEMBER NEW ZEALAND GAZETTE 2821

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Venlafaxine (as the Tablets Ayerst-Wyeth Pharmaceutical Inc., Guayama, Efoxor
hydrochloride) 12.5 mg, Puerto Rico and Wyeth Pharmaceuticals Pty
25 mg, 37.5 mg, 50 mg, Limited, Smithfield, New South Wales,
75 mg, 100 mg Australia
Paracetamol 300 mg, Capsule Uphohn Pty Limited, Rydalmere, New South Orthoxicol 6
guaiphenesin 100 mg, Wales, Australia Congested Cough
pseudoephedrine
hydrochloride 30 mg
Paracetamol 300 mg, Capsule Uphohn Pty Limited, Rydalmere, New South Orthoxicol 9 Dry
dextromethorphan Wales, Australia Cough
hydrobromide 10 mg
Bepridil monohydrochloride Film coated Organon B.V., Oss, The Netherlands Cordium
monohydrate 100 mg, tablets
200 mg, 300 mg
Ketotifen 1 mg/5 ml (as the Syrup Pacific Pharmaceuticals Limited, Mount Asmafen
hydrogen fumarate) Wellington, Auckland

Dated this 18th day of September 1993.

D. SMYTH, Acting Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.

go8090

Consent to the Distribution of Changed Medicines

Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Fluticasone propionate 50 mcg, Rotadisks Glaxo Operations UK Limited, Ware, Flixotide
100 mcg, 250 mcg, 500 mcg Hertfordshire, United Kingdom or Laboratories
per dose Glaxo SA, Evreux La Madeleine, France or
Glaxo New Zealand Limited, Palmerston North
Fluticasone propionate 25 mcg, Metered dose Glaxo Operations UK Limited, Ware, Flixotide
50 mcg, 125 mcg, 250 mcg Hertfordshire, United Kingdom or Laboratories
per actuation Glaxo SA, Evreux La Madeleine, France or
Glaxo Australia Pty Limited, Boronia, Victoria,
Australia
Verapamil 240 mg Slow release Pacific Pharmaceuticals Limited, Mount Verpamil SR
tablets Wellington, Auckland
Octreotide 0.05 mg, 0.1 mg, Injection Sandoz Pharma Limited, Basle, Switzerland Sandostatin
0.5 mg/ml
Recombinant human Powder for Kabi Pharmacia, Stockholm, Sweden Genotropin powder
somatropin 12 IU reconstitution for Injection
for injection
Recombinant human Powder for Kabi Pharmacia, Stockholm, Sweden KabiPen
somatropin 16 IU, 32 IU, reconstitution
36 IU for injection
Recombinant human Powder for Kabi Pharmacia, Stockholm, Sweden KabiQuick
somatropin 2 IU, 3 IU, 4 IU reconstitution
for injection

Dated this 18th day of September 1993.

D. SMYTH, Acting Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.

go8091



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1993, No 136


NZLII PDF NZ Gazette 1993, No 136





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
18 September 1993
Medicines, Approval, Venlafaxine, Paracetamol, Bepridil, Ketotifen
  • D. Smyth, Acting Director-General of Health

πŸ₯ Consent to Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
18 September 1993
Medicines, Approval, Fluticasone, Verapamil, Octreotide, Somatropin
  • D. Smyth, Acting Director-General of Health